Surmodics Inc (SRDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Sales | 29,567 | 28,085 | 29,922 | 33,227 | 30,341 |
| Cost of Goods | 8,576 | 7,830 | 7,425 | 8,674 | 8,448 |
| Gross Profit | 20,991 | 20,255 | 22,497 | 24,553 | 21,893 |
| Operating Expenses | 26,809 | 25,095 | 25,403 | 25,840 | 27,710 |
| Operating Income | -5,242 | -4,010 | -2,481 | -613 | -5,369 |
| Interest Expense | 864 | 855 | 882 | 884 | 879 |
| Other Income | 177 | 183 | 419 | 360 | 437 |
| Pre-tax Income | -5,929 | -4,682 | -2,944 | -1,137 | -5,811 |
| Income Tax | -611 | 527 | 707 | 2,312 | 1,743 |
| Net Income Continuous | -5,318 | -5,209 | -3,651 | -3,449 | -7,554 |
| Net Income | $-5,318 | $-5,209 | $-3,651 | $-3,449 | $-7,554 |
| EPS Basic Total Ops | -0.37 | -0.36 | -0.26 | -0.25 | -0.53 |
| EPS Basic Continuous Ops | -0.37 | -0.36 | -0.26 | -0.24 | -0.53 |
| EPS Diluted Total Ops | -0.37 | -0.36 | -0.26 | -0.25 | -0.53 |
| EPS Diluted Continuous Ops | -0.37 | -0.36 | -0.26 | -0.24 | -0.53 |
| EPS Diluted Before Non-Recurring Items | 0.06 | -0.13 | -0.04 | -0.13 | -0.27 |
| EBITDA(a) | $-3,063 | $-1,796 | $-322 | $1,602 | $-3,160 |